OPCH 📈 Option Care Health - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US68404L2016
OPCH: Infusion Therapies, Nutrition Support, Immunoglobulin Infusions, Nursing Services
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. Web URL: https://www.optioncarehealth.com
Additional Sources for OPCH Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
OPCH Stock Overview
Market Cap in USD | 3,992m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 1996-08-15 |
OPCH Stock Ratings
Growth 5y | 35.2% |
Fundamental | 39.9% |
Dividend | - |
Rel. Strength Industry | -681 |
Analysts | 3.9/5 |
Fair Price Momentum | 19.02 USD |
Fair Price DCF | 44.17 USD |
OPCH Dividends
No Dividends PaidOPCH Growth Ratios
Growth Correlation 3m | -69.2% |
Growth Correlation 12m | -68.6% |
Growth Correlation 5y | 78.8% |
CAGR 5y | 9.71% |
CAGR/Mean DD 5y | 0.72 |
Sharpe Ratio 12m | -0.99 |
Alpha | -70.89 |
Beta | 1.59 |
Volatility | 33.45% |
Current Volume | 5067.9k |
Average Volume 20d | 2103.6k |
What is the price of OPCH stocks?
As of December 22, 2024, the stock is trading at USD 22.91 with a total of 5,067,938 shares traded.
Over the past week, the price has changed by -2.47%, over one month by +4.71%, over three months by -28.18% and over the past year by -29.87%.
As of December 22, 2024, the stock is trading at USD 22.91 with a total of 5,067,938 shares traded.
Over the past week, the price has changed by -2.47%, over one month by +4.71%, over three months by -28.18% and over the past year by -29.87%.
Is Option Care Health a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Option Care Health (NASDAQ:OPCH) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 39.90 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of OPCH as of December 2024 is 19.02. This means that OPCH is currently overvalued and has a potential downside of -16.98%.
Partly, yes. Based on ValueRay Fundamental Analyses, Option Care Health (NASDAQ:OPCH) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 39.90 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of OPCH as of December 2024 is 19.02. This means that OPCH is currently overvalued and has a potential downside of -16.98%.
Is OPCH a buy, sell or hold?
Option Care Health has received a consensus analysts rating of 3.90. Therefor, it is recommend to buy OPCH.
Option Care Health has received a consensus analysts rating of 3.90. Therefor, it is recommend to buy OPCH.
- Strong Buy: 3
- Buy: 3
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecast for OPCH stock price target?
According to ValueRays Forecast Model, OPCH Option Care Health will be worth about 21.2 in December 2025. The stock is currently trading at 22.91. This means that the stock has a potential downside of -7.64%.
According to ValueRays Forecast Model, OPCH Option Care Health will be worth about 21.2 in December 2025. The stock is currently trading at 22.91. This means that the stock has a potential downside of -7.64%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 30.1 | 31.4% |
Analysts Target Price | 41.4 | 80.8% |
ValueRay Target Price | 21.2 | -7.6% |